Structural basis of the synergistic inhibition of glycogen phosphorylase a by caffeine and a potential antidiabetic drug
about
FR258900, a potential anti-hyperglycemic drug, binds at the allosteric site of glycogen phosphorylaseASD v3.0: unraveling allosteric regulation with structural mechanisms and biological networks.Glycogen phosphorylase inhibitors: a patent review (2013 - 2015).Amoebicidal Activity of Caffeine and Maslinic Acid by the Induction of Programmed Cell Death in Acanthamoeba.Synergistic effect of sevoflurane and isoflurane on inhibition of the adult-type muscle nicotinic acetylcholine receptor by rocuronium.Mastoparan binds to glycogen phosphorylase to regulate sarcoplasmic reticular Ca2+ release in skeletal muscle.
P2860
Structural basis of the synergistic inhibition of glycogen phosphorylase a by caffeine and a potential antidiabetic drug
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Structural basis of the synerg ...... a potential antidiabetic drug
@ast
Structural basis of the synerg ...... a potential antidiabetic drug
@en
Structural basis of the synerg ...... a potential antidiabetic drug
@nl
type
label
Structural basis of the synerg ...... a potential antidiabetic drug
@ast
Structural basis of the synerg ...... a potential antidiabetic drug
@en
Structural basis of the synerg ...... a potential antidiabetic drug
@nl
prefLabel
Structural basis of the synerg ...... a potential antidiabetic drug
@ast
Structural basis of the synerg ...... a potential antidiabetic drug
@en
Structural basis of the synerg ...... a potential antidiabetic drug
@nl
P2093
P356
P1476
Structural basis of the synerg ...... a potential antidiabetic drug
@en
P2093
K E Tsitsanou
N G Oikonomakos
V T Skamnaki
P304
P356
10.1006/ABBI.2000.2121
P407
P577
2000-12-15T00:00:00Z